Plain-Language Summary
Plain-language reading of the public trial registries.
In short
- Very little human research on Ipamorelin has been registered.
- 2 registered studies in total.
- None are currently enrolling — this research has already happened.
What kind of research
- 2 studies actually gave the peptide to volunteers and measured what happened. This is the kind of study that can show whether something works.
- About 437 people took part in those.
How far along it is
- None have reached phase 3 — the large, late-stage trials where a drug has to prove itself before regulators will approve it.
- 1 has published results in the medical literature that anyone can read.
A registered trial is a plan, not a result. Registration means a study was declared in advance; it says nothing about whether the peptide worked, and a trial can be registered and then abandoned.
Filter
Showing 2 of 2 trials for Ipamorelin.
Safety and Efficacy of Ipamorelin Compared to Placebo for the Recovery of Gastrointestinal Function
Helsinn Therapeutics (U.S.), Inc
Gastrointestinal Dysmotility
Safety and Efficacy of Ipamorelin for Management of Post-Operative Ileus
Helsinn Therapeutics (U.S.), Inc
Ileus
Sources: ClinicalTrials.gov, the EU Clinical Trials Information System and ISRCTN, deduplicated so a study registered in more than one registry is counted once. A study is listed when Ipamorelin is named as an intervention. A registered trial is a plan, not a result — registration says nothing about whether the peptide worked.